(Q46887182)

English

Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

actinic keratosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

T Ooi

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

R Stc Barnetson

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

L Zhuang

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

S McKane

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

J H Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

H B Slade

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

G M Halliday

7

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

language of work or name

0 references

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

154

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

72-78

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

Immune suppression and skin cancer development: regulation by NKT cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis").

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Malignant transformation of solar keratoses to squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

High prevalence of epidermodysplasia verruciformis-associated human papillomavirus DNA in actinic keratoses of the immunocompetent population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Clinical presentation of actinic keratoses and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

The epidemiology of non-melanoma skin cancer: who, why and what can we do about it.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Advances in the understanding of malignant transformation of keratinocytes: an immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Photoimmunosuppression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Cycle therapy of actinic keratoses of the face and scalp with 5% topical imiquimod cream: An open-label trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Immunocytochemical Analysis of the Cellular Infiltrate in Primary Regressing and Non-Regressing Malignant Melanoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Imiquimod 5% cream in the treatment of Bowen's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Sun Exposure, Skin Cancers and Related Skin Conditions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Imiquimod: modes of action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2005.06932.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2005.06932.X

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16403097

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46887182&oldid=2136249362"